Narrowing the spectrum: The new frontier of precision antimicrobials

Authors

Alexandra E. Paharik, Washington University School of Medicine in St. Louis
Henry L. Schreiber IV, Washington University School of Medicine in St. Louis
Caitlyn N. Spaulding, Washington University School of Medicine in St. Louis
Karen W. Dodson, Washington University School of Medicine in St. Louis
Scott J. Hultgren, Washington University School of Medicine in St. Louis

Journal

Genome Medicine

Publication Date

2017

Volume

9

Inclusive Pages

110

Document Type

Open Access Publication

DOI

10.1186/s13073-017-0504-3

Rights and Permissions

Paharik et al. Genome Medicine (2017) 9:110 DOI 10.1186/s13073-017-0504-3 © The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Recommended Citation

Paharik, Alexandra E.; Schreiber, Henry L. IV; Spaulding, Caitlyn N.; Dodson, Karen W.; and Hultgren, Scott J., "Narrowing the spectrum: The new frontier of precision antimicrobials." Genome Medicine. 9, 110. (2017).
https://digitalcommons.wustl.edu/open_access_pubs/7482